Fundamental Analysis of PAVmed Inc. Series Z WT - Growth / Value Index
PAVMZ - Valuation Highlights
Valuation Analysis
Tsr Value Index - Very Poor Score of 14.29
Book Value in last 3 years is trending down
Book value is negative
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | -30.44 | -6145.88 | -10264637.81 % | |
| Price to Book | -317.38 | -18.07 | -103.70 % | 0 |
| Price to Sales | 853.19 | 286397 | 2020120 % | |
| Enterprise Value to EBITDA Multiple | 0 | -6218.04 | -11587832.58 % |
PAVMZ - Profitability Highlights
Profitability Analysis
Excellent QoQ /QoQ FY EPS growth
Strong Return On Capital Employed of 684.62
Company Earning excess return
Tsr Profitability Index - Very Poor Score of 5.00
Piotroski F Score - Very Poor Value of 2.0
Very Low Dividend Yield of 0 %
Negative Net profit for last two years
Company Net profit is Negative for last 5 Quarters
Negative Net Margin MRQ
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 0 | 0 | 0 % | 0 |
| Return On Asset | -139.10 | -0.213 | 100.00 % | -61.17 |
| Net Profit Margin | -2802.88 | -4660.00 | 80.32 % | -2256.24 |
| Operating Profit Margin | -2340.61 | -5072.81 | 78.97 % | -1389.70 |
| EBITDA Margin | -2340.57 | -4414.06 | 83.28 % | -1389.70 |
Highlights
| Market Cap | 0 |
| Enterprise Value | 0 |
| Price/Book TTM | -317.38 |
| Outstanding Share | 0 |
| Float/ Outstanding Share | % |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 0 |
| Peter Lynch Ratio | 0 |
| Piotroski F Score | 2.00 |
| Altman Z Score | -12.45 |
| Sloan Ratio | -0.0004 |
| Peter Lynch Fair Value | 0 |
PAVMZ - Growth Highlights
Growth Analysis
STRONG JUMP IN NET SALE : YoY growth
Annual sales of the company is increased for three years in a row
Steady increase in Total Assets for last 3 Years
Tsr Growth Index - Very Poor Score of 10.09
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 1968.05 M | 301.86 % | 96182.17 % |
| Gross Profit | -3242.29 M | 51.75 % | 56931.86 % |
| EBITDA | -46063.66 M | 32.80 % | 89541.08 % |
| Net Profit | -55162.04 M | 20.91 % | 162253 % |
| EPS | -0.0020 | 100.00 % | NA |
PAVMZ - Stability Highlights
Stability Analysis
Tsr Stability Index - Very Poor Score of 5.00
Altman Z Score of -12.45 suggest high risk
Company is unable to generate enough free cash to support the business.
Interest Coverage of -88.03
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | -0.0291 | 99.19 % | -0.0194 |
| Cash Ratio | 0.362 | -62.42 % | |
| Quick Ratio | 0.447 | 108.48 % | 0.530 |
| Shareholders Equity | -162.54 | -806.29 % | |
| Debt to EBITDA | -23.40 | -6693488.12 % |
Historical Valuation Ratios of PAVmed Inc. Series Z WT
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of PAVmed Inc. Series Z WT
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of PAVmed Inc. Series Z WT
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of PAVmed Inc. Series Z WT
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)